162 related articles for article (PubMed ID: 33540061)
1. Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model.
Du Y; Yang X; Li J; Sokolova V; Zou S; Han M; Yan H; Wey K; Lu M; Dittmer U; Yang D; Epple M; Wu J
Acta Biomater; 2021 Oct; 133():297-307. PubMed ID: 33540061
[TBL] [Abstract][Full Text] [Related]
2. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
[TBL] [Abstract][Full Text] [Related]
3. Delivery of the TLR ligand poly(I:C) to liver cells in vitro and in vivo by calcium phosphate nanoparticles leads to a pronounced immunostimulation.
Sokolova V; Shi Z; Huang S; Du Y; Kopp M; Frede A; Knuschke T; Buer J; Yang D; Wu J; Westendorf AM; Epple M
Acta Biomater; 2017 Dec; 64():401-410. PubMed ID: 28963016
[TBL] [Abstract][Full Text] [Related]
4. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
5. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles encapsulating hepatitis B virus cytosine-phosphate-guanosine induce therapeutic immunity against HBV infection.
Lv S; Wang J; Dou S; Yang X; Ni X; Sun R; Tian Z; Wei H
Hepatology; 2014 Feb; 59(2):385-94. PubMed ID: 23907803
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
8. JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms.
Herschke F; Li C; Zhu R; Han Q; Wu Q; Lu Q; Barale-Thomas E; De Jonghe S; Lin TI; De Creus A
Antiviral Res; 2021 Dec; 196():105196. PubMed ID: 34718044
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.
Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF
Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.
Zou S; Du Y; Huang S; Chen M; Yang X; Li S; Chen Y; Han M; Li J; Yu Q; Littwitz-Salomon E; Huang H; Trilling M; Liu S; Pei R; Liu J; Wang B; Zheng X; Lu M; Dittmer U; Sun S; Yang D; Wu J
J Virol; 2021 Nov; 95(24):e0003421. PubMed ID: 34550772
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection.
Song J; Zhou Y; Li S; Wang B; Zheng X; Wu J; Gibbert K; Dittmer U; Lu M; Yang D
PLoS One; 2014; 9(3):e90977. PubMed ID: 24618716
[TBL] [Abstract][Full Text] [Related]
12. Genetic immunization against hepatitis B virus with calcium phosphate nanoparticles in vitro and in vivo.
Rojas-Sánchez L; Zhang E; Sokolova V; Zhong M; Yan H; Lu M; Li Q; Yan H; Epple M
Acta Biomater; 2020 Jul; 110():254-265. PubMed ID: 32344172
[TBL] [Abstract][Full Text] [Related]
13. Establishment and primary application of a mouse model with hepatitis B virus replication.
Liu FJ; Liu L; He F; Wang S; Zhou TY; Liu C; Deng LY; Tang H
World J Gastroenterol; 2007 Oct; 13(40):5324-30. PubMed ID: 17879401
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
[TBL] [Abstract][Full Text] [Related]
15. Influence of Pattern Recognition Receptor Ligands on Induction of Innate Immunity and Control of Hepatitis B Virus Infection.
Asadi-Asadabad S; Sarvnaz H; Amiri MM; Mobini M; Khoshnoodi J; Hojjat-Farsangi M; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
Viral Immunol; 2021 Oct; 34(8):531-541. PubMed ID: 34030480
[TBL] [Abstract][Full Text] [Related]
16. Poly(I:C) Induces Distinct Liver Cell Type-Specific Responses in Hepatitis B Virus-Transgenic Mice In Vitro, but Fails to Induce These Signals In Vivo.
Schefczyk S; Luo X; Liang Y; Trippler M; Lu M; Wedemeyer H; Schmidt HH; Broering R
Viruses; 2023 May; 15(5):. PubMed ID: 37243287
[TBL] [Abstract][Full Text] [Related]
17. Local Stimulation of Liver Sinusoidal Endothelial Cells with a NOD1 Agonist Activates T Cells and Suppresses Hepatitis B Virus Replication in Mice.
Huang S; Zou S; Chen M; Gao X; Chen L; Yang X; Yu Q; Zhao X; Du Y; Yang X; Lin Y; Wang B; Lu Y; Liu J; Zheng X; Gong F; Lu M; Yang D; Wu J
J Immunol; 2018 May; 200(9):3170-3179. PubMed ID: 29592964
[TBL] [Abstract][Full Text] [Related]
18. Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review.
Miao J; Gao P; Li Q; He K; Zhang L; Wang J; Huang L
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681886
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen.
Real CI; Lu M; Liu J; Huang X; Trippler M; Hossbach M; Deckert J; Jahn-Hofmann K; Ickenstein LM; John MJ; Gibbert K; Dittmer U; Vornlocher HP; Schirmbeck R; Gerken G; Schlaak JF; Broering R
Sci Rep; 2016 Apr; 6():24865. PubMed ID: 27121087
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection.
Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W
Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
